Resource Guide: Treatment for severe Merkel cell carcinoma after Avelumab

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

In-depth resource

Treatment for severe Merkel cell carcinoma after Avelumab: A Detailed Overview — detailed background and analysis.

National Institutes of Health (NIH)

Reference: National Institutes of Health (NIH)

Authoritative source for clinical, regulatory, and public-health background reading.

Centers for Disease Control and Prevention (CDC)

Reference: Centers for Disease Control and Prevention (CDC)

Authoritative source for clinical, regulatory, and public-health background reading.

ClinicalTrials.gov

Reference: ClinicalTrials.gov

Authoritative source for clinical, regulatory, and public-health background reading.